Cotrimoxazole prophylaxis in adults infected with HIV in low-income countries

Current Opinion in Infectious Diseases

Volumn 14, Issue 5, 2001, Pages 507-512

  Grimwade, Kate ^a   Gilks, Charles ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; AIDS RELATED COMPLEX; CLINICAL TRIAL; COMORBIDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; PROPHYLAXIS; REVIEW; TUBERCULOSIS;

EID: 0034815459     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200110000-00002     Document Type: Review

References (30)

1. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired immunodeficiency
2. Natural history of opportunistic disease in an HIV-infected urban clinical cohort
3. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya
4. Pneumocystis carinii pneumonia: An uncommon cause of death in African patients with acquired immunodeficiency syndrome
5. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya
6. Treatment of gastrointestinal infections
7. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: A cohort study
8. Increasing rates of malarial fever with deteriorating immune status in HIV infected Ugandan adults
9. Drugs for preventing tuberculosis in HIV infected persons
10. 23-Valent pneumococcal polysaccharide vaccine in HIV-1 infected Ugandan adults: A double-blind randomized and placebo controlled trial
11. Evaluation of prophylaxis against invasive pneumococcal infections in human immunodeficiency virus-infected children
12. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients: A randomized controlled trial
13. Early chemoprophylaxis with trimethoprim-sulfamethoxazole for HIV-1 infected adults in Abidjan, Côte d'Ivoire: A randomized trial
14. Efficacy of trimethoprim-sulfamethoxazole prophylaxis to decrease morbidity and mortality in HIV-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: A randomized controlled trial
15. Primary prevention with cotrimoxazole for HIV-1 infected adults: Results of the pilot study in Dakar, Senegal
16. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection
17. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens
18. Initiating cotrimoxazole prophylaxis in HIV-infected patients in Africa: An evaluation of the provisional WHO/UNAIDS recommendations
19. Community-acquired bacteraemia in HIV-positive patients: Protective effect of cotrimoxazole
20. Bacterial infections in adult patients hospitalized with AIDS: Case-control study of prophylactic efficacy of trimethoprim-sulfamethoxazole versus aerosolized pentamidine
21. Role of trimethoprim-sulfamethoxazole in preventing HIV associated bacteraemia
22. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons
23. Risk factors for community acquired pneumonia among persons infected with human immunodeficiency virus
24. The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients
25. Effect of trimethoprim-sulfamethoxazole as pneumocystis prophylaxis on bacterial illness, Pneumocystis carinii pneumonia and death in persons with AIDS
26. Nasopharyngeal colonization with Streptococcus pneumoniae in children receiving trimethoprim-sulfamethoxazole prophylaxis
27. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era
28. Increased carriage of trimethoprim-sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyramethamine